NEW YORK, May 14 – Bioinformatics company Informax said Monday it signed a deal in the first quarter to license its Genomax software to Cellular Genomics.

An Informax spokeswoman said the deal was recorded in the company’s first quarter earnings although the official announcement was held up due to internal delays.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.